http://www.legislation.gov.uk/id/eur/2004/726

F1Article 53

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Annotations:

Amendments (Textual)

F1Regulation revoked insofar as it applies to medicinal products for veterinary use (31.12.2020) by The Veterinary Medicines and Animals and Animal Products (Examination of Residues and Maximum Residue Limits) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/676), regs. 1(2)(b), 5; 2020 c. 1, Sch. 5 para. 1(1)

Regulation revoked insofar as it applies to medicinal products for human use (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), Sch. 9 para. 1(h) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)

F2Regulation revoked insofar as it applies to medicinal products for veterinary use (31.12.2020) by The Veterinary Medicines and Animals and Animal Products (Examination of Residues and Maximum Residue Limits) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/676), regs. 1(2)(b), 5; 2020 c. 1, Sch. 5 para. 1(1)

Regulation revoked insofar as it applies to medicinal products for human use (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), Sch. 9 para. 1(h) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)